| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |